Latest News - Paratek Pharmaceuticals, Inc.

Wednesday, December 20, 2017 | FDA Approval/Clearance, Phase 3/4 Trials,, Paratek Pharmaceuticals, Inc., Allergan

FDA Accepts NDA for Allergan, Paratek Acne Drug

The U.S. Food and Drug Administration accepted a New Drug Application (NDA) to review SeysaraTM(sarecycline) for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older,…

Read the full story